About us

Our strategy

Acquire, Prepare, Commercialise

  • Identify cutting edge technologies in dermatology, oncology and acquire the IP
  • Prepare technologies to valuation realisation
  • Commercialise through a partner, securing a deal that aims to prioritise further development, marketing and early revenue to Incanthera


A rich pipeline of future drug candidates provides the opportunities to develop in line with the business strategy.



Identify (in active negotiations) potential new assets, and through our partnerships and academic teams, prepare assets to point of commercial value.



We aim to seek a commercial deal at the earliest opportunity, minimising the risk profile of time and expense of the traditional model, securing further financial investment back into the portfolio for future development.